Medical Condition

preeclampsia

Total Trials

12

Recruiting Now

12

Trial Phases

Phase 1, Phase 2, EARLY_Phase 1, Phase 3

ClinicalMetric tracks all active clinical trials for preeclampsia sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — preeclampsia Clinical Trials

How many clinical trials are currently recruiting for preeclampsia?

ClinicalMetric currently tracks 12 actively recruiting clinical trials for preeclampsia, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 12. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for preeclampsia?

preeclampsia research spans Phase 1 (3 trials), Phase 2 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a preeclampsia clinical trial?

Eligibility criteria for preeclampsia trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 2

Phase 3

Top Sponsors

Heidelberg University 1 trial

Thomas Jefferson University 1 trial

Rockefeller University 1 trial

IRCCS Azienda Ospedaliero-Universitaria di Bologna 1 trial

IRCCS San Raffaele 1 trial

Recruiting Clinical Trials

NCT07106294

Recruiting

Hyperspectral Imaging for Prediction of Preeclampsia

Heidelberg University

View Trial →

NCT06826859 Phase 1, Phase 2

Recruiting

Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH)

Thomas Jefferson University

View Trial →

NCT05709483 EARLY_Phase 1

Recruiting

Predictors of Aspirin Failure in Preeclampsia Prevention

Rockefeller University

View Trial →

NCT05999851

Recruiting

Multiparametric Assessment of Maternal Vascular Function in the Prediction of Hypertensive Disorders of Pregnancy

IRCCS Azienda Ospedaliero-Univ...

View Trial →

NCT05786235

Recruiting

Patients Pregnant Women With or Without Primary Antiphospholipid Antibody Syndrome

Cardiometabolic Disease and Substrate Metabolism

University of Tennessee Gradua...

View Trial →

NCT07715669 EARLY_Phase 1

Recruiting

Antidepressant Therapy for Improved Blood Vessel Health After Preeclampsia

Placental Imaging Techniques

Lung Ultrasound for the Detection of Volume Overload in Patients With Severe Preeclampsia

Saint Thomas Hospital, Panama

View Trial →

NCT06033131 Phase 3

Recruiting

PI4 - A Trial Assessing Metformin to Prolong Gestation in Preterm Preeclampsia

Enrollment

294 pts

Location

Finland, Norway, Swe...

Endothelial Extracellular Vesicles as Biomarkers of Endothelial Activation in Pregnant Women With Hypertensive Disorders of Pregnancy

Josip Juraj Strossmayer Univer...

View Trial →

NCT07218237

Recruiting

Mindfulness and Wearable Biosensors to Prevent Hypertensive Disorders of Pregnancy

Medical College of Wisconsin

View Trial →

Related Conditions

pregnancy complications (3) preeclampsia pe risk (2) hypertensive disorder of pregnancy (2) pregnancy (2) preterm birth (1) immunologic disease (1) antiphospholipid antibody syndrome primary (1) pregnancy high risk (1) rheumatic diseases (1) gestational diabetes mellitus gdm (1) preeclampsia pe (1) gestational diabetes (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology